Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States

NCT02867722 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The PI decided to not proceed with the trial due to lack of funding.

Conditions

Actinic Keratosis
Non-melanoma Skin Cancer

Interventions

DRUG: aminolevulinic acid HCl

Sponsor

Brigham and Women's Hospital